Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-6.57%
↓ 328% below average
Average (39q)
2.89%
Historical baseline
Range
High:17.17%
Low:-17.33%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -6.57% |
| Q2 2025 | 17.17% |
| Q1 2025 | -17.33% |
| Q4 2024 | 1.71% |
| Q3 2024 | 3.22% |
| Q2 2024 | 13.32% |
| Q1 2024 | -10.85% |
| Q4 2023 | 3.99% |
| Q3 2023 | 1.19% |
| Q2 2023 | 12.51% |
| Q1 2023 | -5.04% |
| Q4 2022 | -0.28% |
| Q3 2022 | -0.21% |
| Q2 2022 | 15.78% |
| Q1 2022 | -8.17% |
| Q4 2021 | 9.77% |
| Q3 2021 | 9.53% |
| Q2 2021 | 11.50% |
| Q1 2021 | -7.80% |
| Q4 2020 | 10.12% |
| Q3 2020 | 4.56% |
| Q2 2020 | 5.60% |
| Q1 2020 | -7.38% |
| Q4 2019 | 7.92% |
| Q3 2019 | -0.03% |
| Q2 2019 | 6.69% |
| Q1 2019 | 5.46% |
| Q4 2018 | 1.65% |
| Q3 2018 | -4.93% |
| Q2 2018 | 13.41% |
| Q1 2018 | -0.11% |
| Q4 2017 | 8.01% |
| Q3 2017 | 4.08% |
| Q2 2017 | 4.20% |
| Q1 2017 | -3.30% |
| Q4 2016 | 3.74% |
| Q3 2016 | -2.05% |
| Q2 2016 | 14.27% |
| Q1 2016 | -1.35% |
| Q4 2015 | 1.40% |